AMEX:LCTX
Lineage Cell Therapeutics, Inc.
- Stock
Last Close
1.04
26/07 20:00
Market Cap
180.52M
Beta: 1.68
Volume Today
614.56K
Avg: 338.18K
PE Ratio
−7.64
PFCF: −5.68
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '13 | Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
asset turnover | 0.05 - | 0.03 47.57% | 0.03 3.02% | 0.02 40.99% | 0.01 34.51% | 0.01 34.66% | 0.01 15.43% | 0.01 39.21% | 0.02 211.71% | 0.12 432.66% | 0.09 25.52% | |
cash conversion cycle | -1.71K - | -2.58K 51.30% | -685.28 73.48% | -7.10K 935.51% | -1.42K 80.02% | -6.85K 383.43% | 1.28K 118.71% | -2.47K 292.90% | 3.86K 255.90% | -1.19K 130.92% | -518.57 56.51% | |
cash per share | 0.10 - | 0.44 337.75% | 0.54 21.55% | 0.23 56.71% | 0.33 42.87% | 0.24 27.36% | 0.21 12.87% | 0.28 31.24% | 0.35 28.07% | 0.34 3.92% | 0.21 39.69% | |
company equity multiplier | 3.90 - | 2.05 47.33% | 3.52 71.33% | 1.21 65.66% | 1.07 11.89% | 1.08 1.70% | 1.11 2.54% | 1.12 1.02% | 1.89 68.67% | 1.69 10.91% | 1.59 5.53% | |
days of inventory outstanding | 82.28 - | 116.00 40.97% | 0.33 99.72% | |||||||||
days of payables outstanding | 1.79K - | 2.97K 65.70% | 922.56 68.90% | 7.28K 689.51% | 2.04K 72.02% | 7.81K 283.30% | 4.63K 40.73% | 2.48K 46.53% | 906.87 63.36% | 1.20K 32.30% | 548.97 54.24% | |
days of sales outstanding | 266.26 - | 236.95 11.01% | 187.52 20.86% | 620.42 230.85% | 958.64 54.52% | 5.91K 516.72% | 1.89 99.97% | 4.76K 252,077.36% | 7.37 99.85% | 30.40 312.31% | ||
dividend yield | 0.00 - | 0.30 16,053.10% | 0.00 99.90% | 0.10 30,735.17% | 0.02 81.14% | 0.00 - | ||||||
ebit per revenue | -19.57 - | -26.04 33.07% | -25.97 0.27% | -26.18 0.82% | -21.71 17.09% | -29.52 35.97% | -26.30 10.89% | -34.21 30.07% | -12.63 63.08% | -1.53 87.87% | -2.77 80.52% | |
ebt per ebit | 1.00 - | 1.01 0.56% | 0.95 5.68% | -0.32 133.17% | 0.60 289.58% | 1.13 88.36% | 0.49 56.13% | 0.83 67.55% | 0.88 6.07% | 1.15 30.36% | 0.94 17.87% | |
effective tax rate | 0.06 - | 0.14 146.95% | 0.07 50.01% | -9.45 13,208.36% | 1.60 116.95% | 0.01 99.54% | 0.39 5,145.59% | 0.06 85.32% | 0.11 92.45% | -0.02 119.27% | 0.08 469.49% | |
enterprise value multiple | -11.08 - | -4.32 61.01% | -4.59 6.13% | -2.34 48.97% | -3.91 66.91% | -2.93 25.12% | -2.31 21.18% | -9.39 307.15% | -6.63 29.36% | -9.64 45.44% | -6.48 32.84% | |
fixed asset turnover | 0.95 - | 0.68 28.64% | 0.34 50.65% | 0.41 21.18% | 0.32 20.48% | 0.24 25.07% | 0.18 25.50% | 0.14 24.06% | 0.80 482.43% | 2.59 224.10% | 1.88 27.60% | |
free cash flow per share | -0.59 - | -0.59 0.97% | -0.63 5.73% | -0.46 26.34% | -0.28 39.65% | -0.27 3.20% | -0.22 17.35% | -0.13 40.65% | -0.15 10.07% | 0.00 102.62% | -0.17 4,551.05% | |
gross profit margin | 0.72 - | 0.57 21.16% | 0.56 1.19% | 0.84 49.35% | 0.91 7.75% | 0.79 13.19% | 0.72 8.32% | 0.50 30.41% | 0.63 26.31% | 0.95 49.92% | 0.85 10.82% | |
interest coverage | -2.15 - | 7.36 442.99% | 3.66 50.31% | 0.76 79.22% | 2.24 194.74% | -3.84 271.62% | -23.07 500.16% | -4.35 - | ||||
inventory turnover | 4.44 - | 3.15 29.07% | 1.11K 35,081.37% | |||||||||
long term debt to capitalization | 0.01 - | 0.16 1,305.09% | 0.02 84.88% | 0.01 69.74% | 0.02 186.41% | 0.03 65.11% | 0.03 23.77% | 0.02 18.66% | 0.04 84.43% | 0.03 18.10% | ||
net income per ebt | 0.78 - | 0.71 8.86% | 0.75 5.38% | 1.80 140.37% | 0.86 52.42% | 0.98 13.76% | 0.61 36.99% | 0.94 53.44% | 0.89 5.54% | 1.02 14.55% | 0.92 9.61% | |
net profit margin | -15.34 - | -18.71 21.97% | -18.54 0.87% | 14.91 180.39% | -11.15 174.78% | -32.48 191.36% | -8.00 75.36% | -26.76 234.41% | -9.90 63.01% | -1.79 81.89% | -2.40 34.01% | |
operating cash flow per share | -0.54 - | -0.58 7.42% | -0.56 4.40% | -0.43 22.17% | -0.27 38.71% | -0.24 8.71% | -0.22 9.79% | -0.13 40.03% | -0.14 8.79% | 0.01 104.35% | -0.17 2,752.60% | |
operating cycle | 82.28 - | 382.26 364.56% | 237.28 37.93% | 187.52 20.97% | 620.42 230.85% | 958.64 54.52% | 5.91K 516.72% | 1.89 99.97% | 4.76K 252,077.36% | 7.37 99.85% | 30.40 312.31% | |
operating profit margin | -19.57 - | -26.04 33.07% | -25.97 0.27% | -26.18 0.82% | -21.71 17.09% | -29.52 35.97% | -26.30 10.89% | -34.21 30.07% | -12.63 63.08% | -1.53 87.87% | -2.77 80.52% | |
payables turnover | 0.20 - | 0.12 39.65% | 0.40 221.56% | 0.05 87.33% | 0.18 257.41% | 0.05 73.91% | 0.08 68.72% | 0.15 87.04% | 0.40 172.96% | 0.30 24.41% | 0.66 118.55% | |
pretax profit margin | -19.64 - | -26.28 33.82% | -24.72 5.93% | 8.27 133.44% | -13.00 257.17% | -33.28 156.11% | -13.01 60.90% | -28.36 117.94% | -11.11 60.84% | -1.76 84.19% | -2.60 48.26% | |
price fair value | 13.19 - | 6.80 48.44% | 12.15 78.71% | 2.98 75.49% | 1.51 49.20% | 1.23 18.68% | 1.15 6.82% | 2.75 139.40% | 4.37 59.20% | 2.71 38.02% | 2.97 9.56% | |
receivables turnover | 1.37 - | 1.54 12.37% | 1.95 26.36% | 0.59 69.77% | 0.38 35.28% | 0.06 83.79% | 193.25 312,917.93% | 0.08 99.96% | 49.51 64,500.53% | 12.01 75.75% | ||
return on assets | -0.76 - | -0.49 36.05% | -0.50 2.12% | 0.24 147.43% | -0.12 148.97% | -0.45 292.33% | -0.09 79.16% | -0.19 103.30% | -0.22 15.30% | -0.21 3.55% | -0.21 0.19% | |
return on capital employed | -1.10 - | -0.75 32.18% | -0.80 7.06% | -0.44 44.92% | -0.23 46.97% | -0.44 88.44% | -0.33 25.85% | -0.26 19.20% | -0.39 46.28% | -0.22 44.29% | -0.30 38.42% | |
return on equity | -2.96 - | -1.00 66.31% | -1.75 74.96% | 0.28 116.29% | -0.12 143.14% | -0.49 299.02% | -0.10 78.64% | -0.22 105.37% | -0.42 94.48% | -0.36 14.07% | -0.34 5.72% | |
total debt to capitalization | 0.01 - | 0.16 1,019.29% | 0.03 79.52% | 0.01 71.41% | 0.02 152.40% | 0.04 85.63% | 0.03 24.15% | 0.03 11.14% | 0.05 71.07% | 0.04 11.83% |
All numbers in USD (except ratios and percentages)